Mechanisms of Protein Misfolding in Conformational Lung Diseases

被引:0
|
作者
McElvaney, N. G. [1 ]
Greene, C. M. [1 ]
机构
[1] Beaumont Hosp, Royal Coll Surg Ireland, Educ & Res Ctr, Resp Res Div,Dept Med, Dublin 9, Ireland
基金
爱尔兰科学基金会;
关键词
Alpha-1; antitrypsin; cigarette smoke; cystic fibrosis transmembrane conductance regulator; endoplasmic reticulum stress; TRANSMEMBRANE CONDUCTANCE REGULATOR; MUTANT ALPHA-1-ANTITRYPSIN Z; MEDIATE INCREASED SECRETION; NUCLEOTIDE-BINDING DOMAIN; CYSTIC-FIBROSIS LUNG; Z ALPHA(1)-ANTITRYPSIN; ENDOPLASMIC-RETICULUM; NEUTROPHIL ELASTASE; CIGARETTE-SMOKE; SERPIN POLYMERIZATION;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Genetic or environmentally-induced alterations in protein structure interfere with the correct folding, assembly and trafficking of proteins. In the lung the expression of misfolded proteins can induce a variety of pathogenetic effects. Cystic fibrosis (CF) and alpha-1 antitrypsin (AAT) deficiency are two major clinically relevant pulmonary disorders associated with protein misfolding. Both are genetic diseases the primary causes of which are expression of mutant alleles of the cystic fibrosis transmembrane conductance regulator (CFTR) and SERPINA1, respectively. The most common and best studied mutant forms of CFTR and AAT are Delta F508 CFTR and the Glu342Lys mutant of AAT called ZAAT, respectively. Non-genetic mechanisms can also damage protein structure and induce protein misfolding in the lung. Cigarette-smoke contains oxidants and other factors that can modify a protein's structure, and is one of the most significant environmental causes of protein damage within the lung. Herein we describe the mechanisms controlling the folding of wild type and mutant versions of CFTR and AAT proteins, and explore the consequences of cigarette-smoke-induced effects on the protein folding machinery in the lung.
引用
收藏
页码:850 / 859
页数:10
相关论文
共 50 条
  • [1] Nanoimaging in protein-misfolding and -conformational diseases
    Uversky, Vladimir N.
    NANOMEDICINE, 2007, 2 (05) : 615 - 643
  • [2] Mechanisms of protein misfolding: Novel therapeutic approaches to protein-misfolding diseases
    Salahuddin, Parveen
    Siddiqi, Mohammad Khursheed
    Khan, Sanaullah
    Abdelhameed, Ali Saber
    Khan, Rizwan Hasan
    JOURNAL OF MOLECULAR STRUCTURE, 2016, 1123 : 311 - 326
  • [3] Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases
    Soto, Claudio
    Pritzkow, Sandra
    NATURE NEUROSCIENCE, 2018, 21 (10) : 1332 - 1340
  • [4] Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases
    Claudio Soto
    Sandra Pritzkow
    Nature Neuroscience, 2018, 21 : 1332 - 1340
  • [5] Protein folding, misfolding and aggregation: Evolving concepts and conformational diseases
    Ramos, CHI
    Ferreira, ST
    PROTEIN AND PEPTIDE LETTERS, 2005, 12 (03): : 213 - 222
  • [6] Conformational diseases: Misfolding mechanisms may pave the way to early therapy
    Reiss, C
    Ehrlich, R
    Lesnick, T
    Parvez, S
    Parvez, H
    NEUROTOXICOLOGY AND TERATOLOGY, 2002, 24 (05) : IX - XIV
  • [7] Defining mechanisms of neurodegeneration associated with protein misfolding diseases
    Lane, Fiona
    PRION, 2012, 6 : 76 - 76
  • [8] Protein Misfolding in Conformational Disorders
    Gomes, Claudio M.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2012, 12 (22) : 2459 - 2459
  • [9] Protein misfolding diseases
    Ventura, Salvador
    FUTURE SCIENCE OA, 2015, 1 (02):
  • [10] Protein Misfolding Diseases
    Hartl, F. Ulrich
    ANNUAL REVIEW OF BIOCHEMISTRY, VOL 86, 2017, 86 : 21 - 26